Recommendations for prevention and control of influenza in children, 2011-2012

Michael T. Brady, Carrie L. Byington, H. Dele Davies, Kathryn M. Edwards, Mary P. Glode, Mary Anne Jackson, Harry L. Keyserling, Yvonne A. Maldonado, Dennis L Murray, Walter A. Orenstein, Gordon E. Schutze, Rodney E. Willoughby, Theoklis E. Zaoutis

Research output: Contribution to journalReview article

38 Citations (Scopus)

Abstract

The purpose of this statement is to update recommendations for routine use of trivalent seasonal influenza vaccine and antiviral medications for the prevention and treatment of influenza in children. The key points for the upcoming 2011-2012 season are that (1) the influenza vaccine composition for the 2011-2012 season is unchanged from the 2010 -2011 season, (2) annual universal influenza immunization is indicated, (3) a simplified dosing algorithm for administration of influenza vaccine to children 6 months through 8 years of age has been created, (4) most children presumed to have egg allergy can safely receive influenza vaccine in the office without need for an allergy consultation, and (5) an intradermal trivalent inactivated influenza vaccine has been licensed for the 2011-2012 season for use in people 18 through 64 years of age. Pediatricians, nurses, and all health care personnel have leadership roles in the prevention of influenza through vaccine use and public education. In addition, pediatricians should promptly identify influenza infections to enable rapid treatment, when indicated, to reduce childhood morbidity and mortality.

Original languageEnglish (US)
Pages (from-to)813-825
Number of pages13
JournalPediatrics
Volume128
Issue number4
DOIs
StatePublished - Oct 1 2011

Fingerprint

Influenza Vaccines
Human Influenza
Egg Hypersensitivity
Inactivated Vaccines
Health Personnel
Antiviral Agents
Immunization
Hypersensitivity
Referral and Consultation
Nurses
Morbidity
Delivery of Health Care
Education
Mortality
Therapeutics
Infection

Keywords

  • Children
  • Immunization
  • Influenza
  • Live-attenuated influenza vaccine
  • Pediatrics
  • Trivalent inactivated influenza vaccine
  • Vaccine

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Brady, M. T., Byington, C. L., Davies, H. D., Edwards, K. M., Glode, M. P., Jackson, M. A., ... Zaoutis, T. E. (2011). Recommendations for prevention and control of influenza in children, 2011-2012. Pediatrics, 128(4), 813-825. https://doi.org/10.1542/peds.2011-2295

Recommendations for prevention and control of influenza in children, 2011-2012. / Brady, Michael T.; Byington, Carrie L.; Davies, H. Dele; Edwards, Kathryn M.; Glode, Mary P.; Jackson, Mary Anne; Keyserling, Harry L.; Maldonado, Yvonne A.; Murray, Dennis L; Orenstein, Walter A.; Schutze, Gordon E.; Willoughby, Rodney E.; Zaoutis, Theoklis E.

In: Pediatrics, Vol. 128, No. 4, 01.10.2011, p. 813-825.

Research output: Contribution to journalReview article

Brady, MT, Byington, CL, Davies, HD, Edwards, KM, Glode, MP, Jackson, MA, Keyserling, HL, Maldonado, YA, Murray, DL, Orenstein, WA, Schutze, GE, Willoughby, RE & Zaoutis, TE 2011, 'Recommendations for prevention and control of influenza in children, 2011-2012', Pediatrics, vol. 128, no. 4, pp. 813-825. https://doi.org/10.1542/peds.2011-2295
Brady MT, Byington CL, Davies HD, Edwards KM, Glode MP, Jackson MA et al. Recommendations for prevention and control of influenza in children, 2011-2012. Pediatrics. 2011 Oct 1;128(4):813-825. https://doi.org/10.1542/peds.2011-2295
Brady, Michael T. ; Byington, Carrie L. ; Davies, H. Dele ; Edwards, Kathryn M. ; Glode, Mary P. ; Jackson, Mary Anne ; Keyserling, Harry L. ; Maldonado, Yvonne A. ; Murray, Dennis L ; Orenstein, Walter A. ; Schutze, Gordon E. ; Willoughby, Rodney E. ; Zaoutis, Theoklis E. / Recommendations for prevention and control of influenza in children, 2011-2012. In: Pediatrics. 2011 ; Vol. 128, No. 4. pp. 813-825.
@article{1d6046ebda0b49f582187ff4f86f19c8,
title = "Recommendations for prevention and control of influenza in children, 2011-2012",
abstract = "The purpose of this statement is to update recommendations for routine use of trivalent seasonal influenza vaccine and antiviral medications for the prevention and treatment of influenza in children. The key points for the upcoming 2011-2012 season are that (1) the influenza vaccine composition for the 2011-2012 season is unchanged from the 2010 -2011 season, (2) annual universal influenza immunization is indicated, (3) a simplified dosing algorithm for administration of influenza vaccine to children 6 months through 8 years of age has been created, (4) most children presumed to have egg allergy can safely receive influenza vaccine in the office without need for an allergy consultation, and (5) an intradermal trivalent inactivated influenza vaccine has been licensed for the 2011-2012 season for use in people 18 through 64 years of age. Pediatricians, nurses, and all health care personnel have leadership roles in the prevention of influenza through vaccine use and public education. In addition, pediatricians should promptly identify influenza infections to enable rapid treatment, when indicated, to reduce childhood morbidity and mortality.",
keywords = "Children, Immunization, Influenza, Live-attenuated influenza vaccine, Pediatrics, Trivalent inactivated influenza vaccine, Vaccine",
author = "Brady, {Michael T.} and Byington, {Carrie L.} and Davies, {H. Dele} and Edwards, {Kathryn M.} and Glode, {Mary P.} and Jackson, {Mary Anne} and Keyserling, {Harry L.} and Maldonado, {Yvonne A.} and Murray, {Dennis L} and Orenstein, {Walter A.} and Schutze, {Gordon E.} and Willoughby, {Rodney E.} and Zaoutis, {Theoklis E.}",
year = "2011",
month = "10",
day = "1",
doi = "10.1542/peds.2011-2295",
language = "English (US)",
volume = "128",
pages = "813--825",
journal = "Pediatrics",
issn = "0031-4005",
publisher = "American Academy of Pediatrics",
number = "4",

}

TY - JOUR

T1 - Recommendations for prevention and control of influenza in children, 2011-2012

AU - Brady, Michael T.

AU - Byington, Carrie L.

AU - Davies, H. Dele

AU - Edwards, Kathryn M.

AU - Glode, Mary P.

AU - Jackson, Mary Anne

AU - Keyserling, Harry L.

AU - Maldonado, Yvonne A.

AU - Murray, Dennis L

AU - Orenstein, Walter A.

AU - Schutze, Gordon E.

AU - Willoughby, Rodney E.

AU - Zaoutis, Theoklis E.

PY - 2011/10/1

Y1 - 2011/10/1

N2 - The purpose of this statement is to update recommendations for routine use of trivalent seasonal influenza vaccine and antiviral medications for the prevention and treatment of influenza in children. The key points for the upcoming 2011-2012 season are that (1) the influenza vaccine composition for the 2011-2012 season is unchanged from the 2010 -2011 season, (2) annual universal influenza immunization is indicated, (3) a simplified dosing algorithm for administration of influenza vaccine to children 6 months through 8 years of age has been created, (4) most children presumed to have egg allergy can safely receive influenza vaccine in the office without need for an allergy consultation, and (5) an intradermal trivalent inactivated influenza vaccine has been licensed for the 2011-2012 season for use in people 18 through 64 years of age. Pediatricians, nurses, and all health care personnel have leadership roles in the prevention of influenza through vaccine use and public education. In addition, pediatricians should promptly identify influenza infections to enable rapid treatment, when indicated, to reduce childhood morbidity and mortality.

AB - The purpose of this statement is to update recommendations for routine use of trivalent seasonal influenza vaccine and antiviral medications for the prevention and treatment of influenza in children. The key points for the upcoming 2011-2012 season are that (1) the influenza vaccine composition for the 2011-2012 season is unchanged from the 2010 -2011 season, (2) annual universal influenza immunization is indicated, (3) a simplified dosing algorithm for administration of influenza vaccine to children 6 months through 8 years of age has been created, (4) most children presumed to have egg allergy can safely receive influenza vaccine in the office without need for an allergy consultation, and (5) an intradermal trivalent inactivated influenza vaccine has been licensed for the 2011-2012 season for use in people 18 through 64 years of age. Pediatricians, nurses, and all health care personnel have leadership roles in the prevention of influenza through vaccine use and public education. In addition, pediatricians should promptly identify influenza infections to enable rapid treatment, when indicated, to reduce childhood morbidity and mortality.

KW - Children

KW - Immunization

KW - Influenza

KW - Live-attenuated influenza vaccine

KW - Pediatrics

KW - Trivalent inactivated influenza vaccine

KW - Vaccine

UR - http://www.scopus.com/inward/record.url?scp=80053556072&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80053556072&partnerID=8YFLogxK

U2 - 10.1542/peds.2011-2295

DO - 10.1542/peds.2011-2295

M3 - Review article

VL - 128

SP - 813

EP - 825

JO - Pediatrics

JF - Pediatrics

SN - 0031-4005

IS - 4

ER -